Description
FLUTICASONE PROPIONATE 100 MCG + VILANTEROL 25MCG
RESVILA Capsules are a fixed-dose combination of Fluticasone Propionate, an inhaled corticosteroid (ICS), and Vilanterol, a long-acting β₂-adrenergic agonist (LABA). This dual therapy provides effective control of asthma and Chronic Obstructive Pulmonary Disease (COPD) by reducing airway inflammation and maintaining long-lasting bronchodilation.
-
Fluticasone Propionate – Reduces airway inflammation, decreases mucus production, and prevents asthma symptoms.
-
Vilanterol – Provides prolonged relaxation of bronchial smooth muscles, improving airflow and reducing breathlessness.
Together, they deliver comprehensive control of asthma and COPD symptoms.
Benefits
Dual action – anti-inflammatory + bronchodilation
Once-daily dosing for patient convenience and better compliance
Proven efficacy in reducing exacerbations and improving lung function
Enhances overall quality of life for patients with chronic airway diseases
